Your browser doesn't support javascript.
loading
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction.
Kita, Yuki; Ito, Katsuhiro; Kanda, Sohei; Joraku, Akira; Yamaguchi, Ritsuki; Shimizu, Yosuke; Hayata, Naoki; Somiya, Shinya; Shibasaki, Noboru; Kimura, Takahiro; Hikami, Kensuke; Yamada, Takeshi; Abe, Takashige; Tsuchihashi, Kazunari; Tatarano, Shuichi; Nishiyama, Hiroyuki; Kitamura, Hiroshi; Kobayashi, Takashi.
Afiliação
  • Kita Y; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ito K; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kanda S; Department of Urology, Akita University, Akita, Japan.
  • Joraku A; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Yamaguchi R; Department of Urology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Shimizu Y; Department of Urology, Kobe City Nishi-Kobe Medical Center, Kobe, Japan.
  • Hayata N; Department of Urology, Kyoto Medical Center, Kyoto, Japan.
  • Somiya S; Department of Urology, Ijinkai Takeda General Hospital, Kyoto, Japan.
  • Shibasaki N; Department of Urology, Otsu City Hospital, Otsu, Japan.
  • Kimura T; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Hikami K; Department of Urology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Yamada T; Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Abe T; Department of Urology, Hokkaido University Graduate School of Medcine, Sapporo, Japan.
  • Tsuchihashi K; Department of Urology, Japanese Red Cross Otsu Hospital, Otsu, Japan.
  • Tatarano S; Department of Urology, Kagoshima University, Kagoshima, Japan.
  • Nishiyama H; Department of Urology, University of Tsukuba, Tsukuba, Japan.
  • Kitamura H; Department of Urology, University of Toyama, Toyama, Japan.
  • Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: selecao@kuhp.kyoto-u.ac.jp.
Urol Oncol ; 40(9): 410.e11-410.e18, 2022 09.
Article em En | MEDLINE | ID: mdl-35551861
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Nefropatias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Nefropatias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão